"mindless rhetoric PP ..at least try to be creative once in

New Post Public Reply Private Reply Replies (1) Message Board
PaperProphet gandalf48 #19727
"mindless rhetoric PP ..at least try to be creative once in a while..."

As I said, you and other investors are mad at me because you could have saved a lot of money by taking my advice...but you didn't. I'm not the one who swindled you. On the contrary, I gave you sound advice.

The thesis is very straight forward. As I brought up in 2010 when I pointed out to investors that the cost of the scrap plastics needed by PTOI are prohibitively expensive. I told investors that the "few months" time line investors were anticipating would be replaced by delay after delay after delay after delay as PTOI came up with excuses to avoid telling investors the truth. Now they have over six years of excuses under their belt why no processor can be placed into profitable operation.

It's very expensive to sort scrap out of the waste stream and similarly expensive to buy it. Today investors have a second data point....

Sure pyrolysis works to depolymerize plastic--it's not magic. However for over five years, PTOI has been unable to find a single profitable situation where they could...

1) get paid to take acceptable plastic from some company which has to pay to dispose of the needed waste plastics anyway or...
2) get acceptable plastic for free from some company which was throwing it away for free or...
3) pay for plastic for which the process could add value.

Now the company, after failing on all fronts, is looking for a company for which one of the above would apply so that customer could find the process useful...and PTOI wants that customer to pay for the processor and do what PTOI was entirely unable to do??

There's a reason why Mr. Bordynuik and Mr. Heddle need to lie and mislead investors to keep moving forward. PTOI's pyrolysis process is just regular pyrolysis--yes, they don't have any magical way of heating up material in an oxygen-reduced chamber to break down plastic into an oil. To sell shares, PTOI has to continue to dupe unwitting investors.

Plastic2Oil, Inc. (PTOI) Stock Research Links

PTOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Yes, I understand your penny stock also is the real deal, created with the inventiveness of Edison and destined to be the next Microsoft. Yes, I understand that the delays are also only because your company is making their product and/or technology even more revolutionary.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 69

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 573

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 343

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 158

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 587

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 116

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 437

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 131

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

WISeKey Enhances Digital ID Solutions Across Africa

Updated Category News Views 199

WISeKey Expands Its Digital Identity Footprint Across Africa WISeKey International Holding Ltd is making significant strides in transforming digital identity solutions not only within Seychelles but also expanding into several other African nations. As a prominent player in cybersecurity, blockchain, and IoT, WISeKey is set to revolutionize how national ID systems...

Continue Reading
How to Send Event Leads Directly into Your CRM

Updated Category Business Views 149

Trade shows and conferences generate some of the highest-intent leads a sales team will ever encounter. Yet many of those conversations never convert—not because the prospect lost interest, but because the follow-up arrived too late or the contact details were lost somewhere between a badge scanner and a spreadsheet. Research from event marketing surveys consistently...

Continue Reading
Dreame Technology's Innovative Smart Home Solutions at CES 2025

Updated Category News Views 474

Dreame Technology Showcases Innovative Solutions at CES 2025 Dreame Technology, a pioneer in smart home solutions, has made waves at CES 2025 with the introduction of its next-generation smart home ecosystem. This new system streamlines home management and enhances everyday living through intelligent appliances that are easy to use and highly efficient. Revolutionizing...

Continue Reading
Astemo Flexes Aftermarket Muscles at 2026 AAPEX & SEMA

Updated Category News Views 374

Ah, nothing gets car enthusiasts more revved up than a good old-fashioned auto show unveiling. Astemo Americas is strutting its stuff at the 2026 AAPEX and SEMA shows, and they're not just shooting the breeze—this company has got some serious aftermarket muscle to flex. Pumping Up the Aftermarket Game Astemo's not sitting on its hands when it comes to expanding its...

Continue Reading
Cocoa Prices Plummet, Boosting Chocolate Makers Before Holidays

Updated Category News Views 253

Cocoa Prices Reach New Lows Recently, cocoa futures dropped to their lowest point in nearly two years, which is quite timely as we approach the season for hot chocolate and festive gifting. This price decline acts as a unique advantage for chocolate manufacturers who are just starting to see some relief after facing escalating ingredient costs over the past year, coupled...

Continue Reading